The pharmaceutical industry is rapidly evolving, with substantial demand for high-efficacy Active Pharmaceutical Ingredients (APIs). Dulaglutide, a GLP-1 receptor agonist, represents example of this trend. To fulfill https://mediajx.com/story25378791/prominent-us-based-dulaglutide-api-manufacturing-services